Faulty stock of Children's Panadol dosing gadget used by certain parents have been requested to take their kids to see doctors quickly on the grounds that they are at danger of genuine liver harm.
It shows up that dose data was printed further up inside the syringe than normal, possibly befuddling folks into giving their youngsters more pharmaceutical than needed.
Novartis AG (NOVN. VX) the Swiss drugmaker is planning to buy back $5 billion of its shares.
The buyback is part of a $10 billion programme authorised by investors in 2008 and which was partially resumed in 2010 to pacify shareholders in the awakening of Novartis' $39 billion purchase of the rest of eye care firm Alcon.
GlaxoSmithKline was having many hopes from its new drug under trial. The drug, Darapladib, is meant to prevent the rupturing of atherosclerotic plaques, which leads to coronary heart disease.
Ranbaxy Laboratories, India's major drug manufacturing company, has been charged of presenting false test results to get the USFDA nod. Dinesh Thakur is an ex-employee of the company, who has also been charged in the company. It has been said that the company did so in order to sell its generic drugs in the market.
Eisai Pharmatechnology and Manufacturing Pvt Ltd which is based in Vishakhapatnam stated this week that it has begun supplying free Diethylcarbamazine Citrate (DEC) 100 mg tablets to the World Health Organization (WHO).
This medicine, DEC, is used for the treatment of lymphatic filariasis which is more commonly known as elephantiasis and is a tropical disease.
Drug-maker Shire is having good time as its shares are witnessing new high. Past few months have proved to be quite lucrative for pharmaceuticals giant Shire when it comes to shares.
Its shares in recent months have regularly been hitting records. In fact, the company has delivered better performance than expected in its third quarter.
Good News USA
- Vodafone NZ’s new ‘Red Home’ packages will offer UFB and 150 TV channels
- Vodafone NZ’s full-year profit plunged by more than two-thirds to $56 million
- Vodafone adding 34 European countries to ‘AU$5 per day’ international roaming option
- Telstra launches its new ‘Every Day Connect Data Share Packages’
- Voyager signs “multimillion-dollar deal” with submarine cable group Hawaiki